RYBRILA Trademark

Trademark Overview

On Tuesday, April 6, 2021, a trademark application was filed for RYBRILA with the United States Patent and Trademark Office. The USPTO has given the RYBRILA trademark a serial number of 90627459. The federal status of this trademark filing is REGISTERED as of Tuesday, April 25, 2023. This trademark is owned by Clinigen Healthcare Limited. The RYBRILA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anticholinergic pharmaceutical preparations for the treatment of sialorrhea
rybrila

General Information

Serial Number90627459
Word MarkRYBRILA
Filing DateTuesday, April 6, 2021
Status700 - REGISTERED
Status DateTuesday, April 25, 2023
Registration Number7033557
Registration DateTuesday, April 25, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anticholinergic pharmaceutical preparations for the treatment of sialorrhea
Translation of Words in MarkThe wording "RYBRILA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameClinigen Healthcare Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStaffordshire DE142WW
GB
Party NameClinigen Healthcare Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStaffordshire DE142WW
GB
Party NameClinigen Healthcare Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStaffordshire DE142WW
GB

Trademark Events

Event DateEvent Description
Monday, August 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 25, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 5, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, January 5, 2023ASSIGNED TO LIE
Thursday, January 5, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 5, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, January 5, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, December 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 15, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 14, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, July 14, 2022INQUIRY TO SUSPENSION E-MAILED
Thursday, July 14, 2022SUSPENSION INQUIRY WRITTEN
Thursday, July 7, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, June 15, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, November 22, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 22, 2021LETTER OF SUSPENSION E-MAILED
Monday, November 22, 2021SUSPENSION LETTER WRITTEN
Friday, November 19, 2021ASSIGNED TO EXAMINER
Thursday, July 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 9, 2021NEW APPLICATION ENTERED

Related Keywords

rybrila pharmaceutical preparations sialorrhea treatment namely anticholinergic